Key result
NH29 acts as a nontoxin gating modifier that increases Kv7.2 currents, depresses evoked spike discharges in neurons, and dampens hippocampal glutamate and GABA release.
NH29 acts as a non-toxin gating modifier targeting the voltage-sensing domain of Kv7.2 channels, providing a structural framework for designing treatments for hyperexcitability disorders.
No takes yet. Share an insight, caveat, or question.
NH29 supports preclinical exploration of Kv7.2 modulation for hyperexcitability; clinical translation remains untested.
Peretz et al. (2010) studied Hyperexcitability disorders. NH29 was evaluated on Kv7.2 currents, spike discharges, and neurotransmitter release. NH29 acts as a nontoxin gating modifier that increases Kv7.2 currents, depresses evoked spike discharges in neurons, and dampens hippocampal glutamate and GABA release.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: